| Hepatitis C in hemodialysis patients needs more attention for control and review the risk factors Seyed-Moayed Alavian Professor of Gastroenterology and Hepatology, Baqiyatallah Research Center for Gastroenterology and Liver Diseases, P.O. Box 14155-3651, Tehran, Iran | |
We read with great interest the published article by Al-Jamal et al [1] about hepatitis C in fection (HCV) in hemodialysis patients in a region in Jordan. I agree with the authors about the importance of HCV infection in hemodia lysis patients, [2] but some points need clarifi cation. The prevalence of HCV infection among dialysis patients varies markedly from country to country and among dialysis centers within a single country. [3] The authors found the similar data, but it would have been better to discus more about the use of erythropoietin, universal precautions, health care services and number of nurses to the patients in the centers.
The results in the study confirm that duration of dialysis more than two years and number of transfusion as risk factors for higher preva lence of HCV compatible with other studies, [3],[4] however, the duration of hemodialysis may in directly reflect the number of blood transfu sions given, it was not clear if the time on hemodialysis was indeed an independent risk factor. Interestingly, 32% of their hemodialysis patients did not have history of blood trans fusion and evaluating this group separately would have been more informative in terms of duration or sessions per week as a direct risk factor for HCV.
Read article in full here
No comments:
Post a Comment